Includes Detailed Profiles of Industry Giants Eli Lilly & Company, Pfizer, Sun Pharmaceutical Industries, Arcutis Biotherapeutics, Bristol-Myers Squibb, AbbVie, Regeneron Pharmaceuticals, and Aclaris ...

Careful examination of clinical trial data and a better understanding of risk factors can help rheumatologists determine if a ...

Researchers at the Garvan Institute of Medical Research and UNSW Sydney have discovered why some people with celiac disease ...

Takeda is organized around five core businesses: oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for over 80% of revenue. It also has a developing ...

Scientists have identified mutated immune cell clones that could point to improved treatment for refractory celiac disease.

Researchers at the Garvan Institute of Medical Research and UNSW Sydney have discovered why some people with coeliac disease continue to suffer ...

"For example, we found that many of these aberrant cells have mutations in the JAK-STAT pathway, which is already targeted by approved drugs known as JAK inhibitors. With more investigation ...

For example, in patients with cytopenic adverse events [AEs ... I would say that it is disease progression. However, our JAK inhibitors do differ in their myelosuppressive potential, and some of the ...

Scientists have identified mutated immune cell clones that could point to improved treatment for refractory celiac disease.

Meeting of the European Society for Blood and Marrow Transplantation (EBMT) was held this year in the vibrant city ...